Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ligang Chen

Showing results (311-320 of 318) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 318 results.
Biotechnology Advances|December 21, 2024
Terahertz scanning near-field optical microscopy for biomedical detection: Recent advances, challenges, and future perspectivesShihan Yan, Guanyin Cheng, Zhongbo Yang, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Communications Biology|January 20, 2025
Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4Zhe Huang, Ming Wang, Yitian Chen, et al.
Journal of Materials Chemistry. B|January 2, 2024
Integrated metabolomics revealed the photothermal therapy of melanoma by Mo<sub>2</sub>C nanosheets: toward rehabilitated homeostasis in metabolome combined lipidomeDingkun Zhang, Ming Wang, Yijin Li, et al.
Pathology, Research and Practice|November 26, 2022
UCHL1 promotes cancer stemness in triple-negative breast cancerChuntao Tian, Ying Liu, Yixiong Liu, et al.
Eclinicalmedicine|March 8, 2021
Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): A multicenter randomized controlled trialJiyuan Hui, Junfeng Feng, Yue Tu, et al.
Chinese Medical Journal|September 30, 2022
Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)Jiaojiao Deng, Lingyang Hua, Liuguan Bian, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Pageof 32

Showing results (311-320 of 318) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
Biotechnology Advances|December 21, 2024
Terahertz scanning near-field optical microscopy for biomedical detection: Recent advances, challenges, and future perspectivesShihan Yan, Guanyin Cheng, Zhongbo Yang, et al.
Cancer Letters|December 20, 2015
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsNiyati Jhaveri, Fabienne Agasse, Don Armstrong, et al.
Communications Biology|January 20, 2025
Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4Zhe Huang, Ming Wang, Yitian Chen, et al.
Journal of Materials Chemistry. B|January 2, 2024
Integrated metabolomics revealed the photothermal therapy of melanoma by Mo<sub>2</sub>C nanosheets: toward rehabilitated homeostasis in metabolome combined lipidomeDingkun Zhang, Ming Wang, Yijin Li, et al.
Pathology, Research and Practice|November 26, 2022
UCHL1 promotes cancer stemness in triple-negative breast cancerChuntao Tian, Ying Liu, Yixiong Liu, et al.
Eclinicalmedicine|March 8, 2021
Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): A multicenter randomized controlled trialJiyuan Hui, Junfeng Feng, Yue Tu, et al.
Chinese Medical Journal|September 30, 2022
Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)Jiaojiao Deng, Lingyang Hua, Liuguan Bian, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Pageof 32